1-9 of 9
Ole Gadeberg
Close
Sort by
Journal Articles

Ofatumumab (OFA) in Combination with CHOP for Previously Untreated Follicular Lymphoma: Follow-up Results

Myron S. Czuczman, MD, Georg Hess, Ole Gadeberg, Lars Moeller Pedersen, Per Hansen, David Belada, M.D., Ph.D., Stephanie A. Gregory, MD, Brad Pohlman, MD, Jiri Mayer, M.D., PhD., Prof., Robert Pytlik, Lorenz Trumper, Andreas Viardot, MD, Ira V. Gupta, MD, Thomas S. Lin, MD, PhD, Paul Winter, Nancy Goldstein, Roxanne C. Jewell, PhD, Steen Lisby, MD, DMSc
Journal: Blood
Blood (2012) 120 (21): 1632.
https://doi.org/10.1182/blood.V120.21.1632.1632
Published: 2012
Journal Articles

A New Simplified Prognostic Index with Age Cut-off of 70 Years for Patients with Diffuse Large B-Cell Lymphoma. A Population-Based Analysis From the Danish Lymphoma Registry, LYFO

Anne Ortved Gang, Michael Pedersen, MD, Francesco d'Amore, Lars Møller-Pedersen, MD, PhD, Bo Amdi Pedersen, Paw Jensen, Bjarne Bach Pedersen, Michael B. Møller, MD, DMSc, Ole Gadeberg, Steen Ingeberg, Torben mourits-Andersen, MD, Stanislaw Pulczynski, Tobias Wirenfeldt Klausen, Peter De Nully Brown
Journal: Blood
Blood (2012) 120 (21): 3651.
https://doi.org/10.1182/blood.V120.21.3651.3651
Published: 2012
Journal Articles

High-Dose Chemotherapy and Autologuos Stem Cell Transplantation in Previously Untreated Peripheral T-Cell Lymphoma - Final Analysis of a Large Prospective Multicenter Study (NLG-T-01)

Francesco d'Amore, MD, DMSci, Thomas Relander, Grete F. Lauritzsen, Esa Jantunen, Hans Hagberg, Harald Anderson, Harald Holte, Jr., Anders Österborg, Mats Merup, Peter de Nully Brown, Outi Kuittinen, Martin Erlanson, Bjørn Østenstad, Unn-Merete Fagerli, Ole Gadeberg, Christer Sundström, Jan Delabie, MD, PhD, Elisabeth Ralfkiaer, Martine Vornanen, Helle Toldbod
Journal: Blood
Blood (2011) 118 (21): 331.
https://doi.org/10.1182/blood.V118.21.331.331
Published: 2011
Journal Articles

Intensive Induction Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) In Patients with Enteropathy-Associated T-Cell Lymphoma: a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Esa Jantunen, Thomas Relander, Grete Fossum Lauritzsen, MD, Hans Hagberg, MD, Harald Anderson, PhD, Eva Cavallin-Ståhl, MD, Harald Holte, Anders Østerborg, MD, Mats Merup, MD, Peter De Nully Brown, MD, Outi Kuittinen, MD, Martin Erlanson, MD, Bj∅rn Østenstad, MD, Unn-Merete Fagerli, MD, Ole Gadeberg, MD, Christer Sundstrom, MD, PhD, Jan Delabie, MD, Elisabeth Ralfkiaer, MD, Martine Vornanen, MD, Francesco d’Amore
Journal: Blood
Blood (2010) 116 (21): 3565.
https://doi.org/10.1182/blood.V116.21.3565.3565
Published: 2010
Journal Articles

Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01)

Thomas Relander, MD, Grete Fossum Lauritzsen, MD, Esa Jantunen, MD, Hans Hagberg, MD, Harald Anderson, PhD, Eva Cavallin-Ståhl, MD, Harald Holte, MD, Anders Østerborg, MD, Mats Merup, MD, Peter De Nully Brown, MD, Bj∅rn Østenstad, MD, Outi Kuittinen, MD, Martin Erlanson, MD, Unn-Merete Fagerli, MD, Ole Gadeberg, MD, Christer Sundstrom, MD, PhD, Jan Delabie, MD, Elisabeth Ralfkiaer, MD, Martine Vornanen, MD, Francesco d’Amore
Journal: Blood
Blood (2010) 116 (21): 3566.
https://doi.org/10.1182/blood.V116.21.3566.3566
Published: 2010
Journal Articles

Epidemiological and Clinico-Pathological Features of Systemic Peripheral T-Cell Lymphomas (PTCL): A Population-Based Analysis from the Danish Lymphoma Registry LYFO

Francesco d’Amore, MD, Peter de Nully Brown, Lars Moeller Pedersen, Anne Bukh, Per Boye Hansen, Bjarne Bach Pedersen, Ole Gadeberg, Michael Pedersen, Steen Ingeberg, Stanislaw Pulczynski, Torben Mourits Andersen, Michael Moeller
Journal: Blood
Blood (2008) 112 (11): 3766.
https://doi.org/10.1182/blood.V112.11.3766.3766
Published: 2008
Journal Articles

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

Clinical Trials & Observations
Anton Hagenbeek, Ole Gadeberg, Peter Johnson, Lars Møller Pedersen, Jan Walewski, Andrzej Hellmann, Brian K. Link, Tadeusz Robak, Marek Wojtukiewicz, Michael Pfreundschuh, Michael Kneba, Andreas Engert, Pieter Sonneveld, Mimi Flensburg, Jørgen Petersen, Nedjad Losic, John Radford
Journal: Blood
Blood (2008) 111 (12): 5486–5495.
https://doi.org/10.1182/blood-2007-10-117671
Published: 2008
Journal Articles

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

Clinical Trials & Observations
Bertrand Coiffier, Stéphane Lepretre, Lars Møller Pedersen, Ole Gadeberg, Henrik Fredriksen, Marinus H. J. van Oers, James Wooldridge, Janusz Kloczko, Jerzy Holowiecki, Andrzej Hellmann, Jan Walewski, Mimi Flensburg, Jørgen Petersen, Tadeusz Robak
Journal: Blood
Blood (2008) 111 (3): 1094–1100.
https://doi.org/10.1182/blood-2007-09-111781
Published: 2008
Journal Articles

Dose-Dense Induction Followed by Autologous Stem Cell Transplant (ASCT) as 1st Line Treatment in Peripheral T-Cell Lymphomas (PTCL) - A Phase II Study of the Nordic Lymphoma Group (NLG).

Francesco d’Amore, MD, Thomas Relander, MD, Grete Lauritzsen, MD, Esa Jantunen, MD, Hans Hagberg, MD, Harald Anderson, PhD, Eva Cavallin-Ståhl, MD, Harald Holte, MD, Anders Østerborg, MD, Mats Merup, MD, Mads Hansen, MD, Ragnar Telhaug, MD, Martin Erlanson, MD, Outi Kuittinen, MD, Ole Gadeberg, MD, Jan Delabie, MD, Christer Sundström, MD, Elisabeth Ralfkiær, MD, Martine Vornanen, MD, Charlotte B. Jensen, MD
Journal: Blood
Blood (2006) 108 (11): 401.
https://doi.org/10.1182/blood.V108.11.401.401
Published: 2006